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 13 
The bacterial cell wall is a highly conserved essential component of most bacterial groups. It is the 14 
target for our most frequently used antibiotics and provides important small molecules that 15 
trigger powerful innate immune responses. The wall is composed of glycan strands cross-linked by 16 
short peptides. For many years, the penicillin binding proteins were thought to be the key 17 
enzymes required for wall synthesis. RodA and possibly other proteins in the wider SEDS family 18 
have now emerged as a previously unknown class of essential glycosyltranferase enzymes, which 19 
play key morphogenetic roles in bacterial cell wall synthesis. We provide evidence in support of 20 
this role and the discovery of small natural product molecules that probably target these enzymes. 21 
The SEDS proteins have exceptional potential as targets for new antibacterial therapeutic agents.  22 
 23 
The bacterial cell wall is an ancient structure that was probably invented early in the evolution of 24 
cells and may have contributed to the explosive bacterial radiation that occurred about 3-4 billion 25 
years ago1. The wall is essential for bacterial viability and an important target for antibiotics2. The 26 
major conserved component of the wall is peptidoglycan (PG), which comprises long strands of 27 
alternating amino sugars cross-linked by peptide bridges. The key enzymes needed for assembly of 28 
the wall are glycosyltransferases (GTase), which generate the glycan strands and transpeptidases 29 
(TPase), which generate the cross-links3. Penicillin-binding proteins (PBPs), first identified because 30 
they bind β-lactam antibiotics that prevent the TPase reaction, were considered to be the key 31 
enzymes in PG assembly because one major class (class A) also carry a GTase domain capable of 32 
synthesising PG strands. A second major class of PBPs (class B) lack the GTase domain. Curiously, the 33 
class B PBPs more frequently display genetic essentiality than the class A PBPs. Furthermore, their 34 
mutant phenotypes suggest that they play specialised roles in morphogenesis; thus, mutants of rod-35 
shaped bacteria such as Escherichia coli can be specifically affected in either cell elongation (e.g. 36 
pbpA gene) or cell division (ftsI gene)4. Bacillus subtilis has two redundant elongation enzymes, 37 
PBP2A and PBPH5, and an essential division enzyme, PBP2B6. 38 
pbp genes show a remarkable level of functional redundancy, possibly reflecting the selective 39 
pressure exerted by antibiotic use, either in the natural environment or the human sphere. About 10 40 
years ago, the Popham lab reported the unexpected finding that in B. subtilis, the genes encoding all 41 
four class A PBPs could be inactivated without significantly affecting cell growth or division7. This 42 
pointed to the existence of a “missing GTase”. Here we identify RodA, a highly conserved member of 43 
the SEDS (shape, elongation, division and sporulation8) family of proteins, as a strong candidate for 44 
the missing GTase. Our findings are in line with those of other labs published while this work was 45 
under review9. We go on to describe the results of a chemical genetics screen for inhibitors of the 46 
missing GTase, which has led to the isolation of a novel antibacterial compound that probably 47 
targets RodA.  48 
The multiple class A PBP mutant is resistant to moenomycin and hypersensitive to loss of 49 
σM 50 
We repeated the Popham lab construction of a B. subtilis strain bearing deletions of the genes 51 
encoding all 4 class A PBPs (ponA, pbpD, pbpF and pbpG; strain AG157, hereafter “Δ4”)7 and showed 52 
that it is indeed viable, though the cells grow relatively slowly and require elevated levels of Mg++. 53 
The strain closely resembles a single ponA mutant, which presumably encodes the “major” class A 54 
PBP activity under normal conditions, in having cells that are slightly longer and thinner than wild 55 
type. If the missing GTase had a similar GTase active site to that of the class A PBPs it should be 56 
sensitive to the known GTase inhibitor, moenomycin (MOE)10. However, Popham’s lab previously 57 
reported that the Δ4 mutant is relatively insensitive to MOE and that its growth resembles that of 58 
the wild type treated with MOE7, raising the possibility that the missing GTase is MOE resistant. 59 
Significantly, we found that the Δ4 mutant was actually more resistant to MOE than the wild type 60 
under certain conditions (Fig. 1a), suggesting that an MOE resistant form of GTase is upregulated in 61 
the Δ4 mutant, in response to loss of the class A PBP activities. In preliminary RNA-Seq experiments 62 
comparing wild type and Δ4 strains many of the higher expressed genes in the Δ4 strain overlapped 63 
with genes belonging to the cell wall stress ECF sigma factor σM11 (Supplementary Table 1). Other 64 
genes belonged to a gene set recognised as being stimulated by treatment of cells with the antibiotic 65 
MOE12. Salzberg et al.12 had shown that σM is upregulated in response to MOE stress and that a sigM 66 
mutant is hypersensitive to MOE. To test whether σM upregulation was indeed contributing to the 67 
increased MOE resistance of the Δ4 mutant, we tried to introduce a sigM mutation into the Δ4 strain 68 
but this combination was apparently lethal. Instead, we introduced the sigM mutation into a Δ4 69 
mutant that carried a plasmid containing an inducible copy of ponA, generating a strain in which 70 
sigM could be knocked out. As shown in Fig. 1b, growth of this strain was dependent on the 71 
expression of ponA (+IPTG), confirming that sigM is essential in the Δ4 mutant (Fig. 1b). Consistent 72 
with the notion that PBP1A, the product of the ponA gene, is the major bifunctional PBP in B. 73 
subtilis7,13, it was also not possible to introduce the sigM mutation into cells bearing only a ponA 74 
mutation.  75 
rodA is the σM regulon gene responsible for enhanced resistance to MOE 76 
We took a candidate gene approach to look for genes that might be responsible for the σM-77 
dependence of MOE resistance. Table 1 summarises the genes identified on the basis of σM-78 
dependence and/or MOE-stimulation, supported by the preliminary RNA-Seq data (further details in 79 
Supplementary Table 1). Knockouts of all of the non-essential genes with unknown or poorly 80 
understood function (51 in total; mainly “y genes”) were examined but, with one exception, none of 81 
them showed significantly increased sensitivity to MOE. As previously described14, mutants of yabM 82 
did show significant sensitivity. However, mutation of this gene did not affect viability when 83 
introduced into the Δ4 background, suggesting that it is not essential for the alternative GTase: 84 
indeed, Meeske et al.15 recently showed that YabM belongs to a family of probable lipid II flippases, 85 
rather than being a GTase. We therefore considered the essential gene candidates. Of these, most 86 
have already had biochemical functions assigned to them, particularly around lipid II (cell wall) 87 
synthesis (Supplementary Table 1). Five genes of unknown biochemical function remained: divIB, 88 
divIC, mreC, mreD, and rodA. The first two of these genes appear to be required specifically for cell 89 
division16, and so were excluded from further study. The remaining three genes, mreC, mreD and 90 
rodA, are all required for cell elongation and generate a similar bloated cell phenotype when 91 
depleted8,17,18. All three genes were initially considered to be essential in B. subtilis but null mutants 92 
can be constructed and propagated in media containing osmoprotectants and high levels of 93 
Mg++18,19. Mutants in each of the three genes turned out to be hypersensitive to MOE (Fig. 1c), 94 
making them contenders for the missing GTase. mreC and mreD are usually located in an operon 95 
downstream of the gene encoding the bacterial actin homologue, mreB, and so have been assumed 96 
to have some role in coupling MreB function to other proteins involved in cell wall synthesis. 97 
Alignments of MreC and MreD sequences from a range of organisms revealed relatively weak 98 
sequence conservation, especially for the very hydrophobic MreD protein (not shown). Neither 99 
protein seemed a good candidate for an enzyme, since no amino acid group of character typically 100 
required for catalysis (e.g. C, D, E, H, K, R, S, T) was conserved in the alignments. In contrast, 101 
sequence alignments of RodA and related SEDS proteins revealed several highly conserved, 102 
potentially catalytic amino acids, including (B. subtilis RodA numbering): E117 (2/62 exceptions), 103 
K120 (1/62 exceptions), R229, D280 and S360 (Supplementary Fig. 1). Until recently, SEDS proteins 104 
were thought to encode lipid II flippases, but the MurJ and Amj proteins now appear to fulfil this role 105 
in E. coli and B. subtilis15, so we initially focussed on RodA.  106 
We built conditional and overexpression systems for rodA and used them to test for effects on 107 
sensitivity to MOE and ability to impair or enhance the growth of ponA or Δ4 mutants. Previous work 108 
showed that depletion of rodA (using an IPTG-dependent promoter, Pspac) can be tolerated in the 109 
presence of osmoprotectant (sucrose) and 20 mM Mg++ (19 and Fig. 2a, “Wt”). However, RodA 110 
depletions in ΔponA or Δ4 backgrounds were lethal (Fig. 2a). Figure 2b shows an equivalent set of 111 
experiments in which sensitivity to depletion of RodA was tested in liquid culture, again in the 112 
presence of sucrose and Mg++. Growth of the control strain continued over at least 4 hours of rodA 113 
repression, whereas for either the ponA or Δ4 background strains, culture optical densities declined 114 
after about 2 hours. Microscopic examination of rodA depletion in an otherwise wild type 115 
background revealed a gradual loss of the normal cylindrical phenotype, as expected for a classic 116 
rodA mutant (Fig. 2c, upper panels). Surprisingly, when RodA was depleted in either of the class A 117 
PBP defective strains the characteristic gradual rounding did not occur: instead the cells stopped 118 
growing but remained cylindrical and then underwent extensive lysis (the rounded objects in the 119 
figure are phase contrast “pale”, having undergone lysis). Thus, class A PBP activity is required for 120 
both continued growth and cell integrity, and for development of the aberrant morphology 121 
characteristic of rodA mutant cells.  122 
We previously noted that ponA mutants grow particularly poorly on PAB medium, which supports 123 
virtually normal growth of wild type cells20. The Δ4 mutant had a similar growth defect on PAB 124 
medium, which could be corrected by induction of ponA expression from a plasmid-borne copy (Fig. 125 
2d, 1 mM IPTG). Importantly, robust growth of the Δ4 mutant on PAB medium could also be 126 
achieved when rodA was overexpressed from an extra copy of the gene under xylose-inducible 127 
control. Thus, overproduction of RodA seems to ameliorate at least some of the growth deficiencies 128 
of the class A PBP defective mutants. B. subtilis (and most bacteria) have a second essential SEDS 129 
protein, FtsW, which is required specifically for cell division16. This gene does not seem to be subject 130 
to σM control11,12 and indeed, overexpression of ftsW did not rescue growth (Fig. 2d, 1% xylose). 131 
We showed above that it is not possible to combine sigM and ponA mutations under normal 132 
conditions. Figure 2e shows that overexpression of rodA was also sufficient to enable robust growth 133 
of a sigM Δ4 multiple mutant, consistent with rodA encoding the sole sigM regulated product 134 
needed for growth in the absence of class A PBPs.  135 
MOE is a specific inhibitor of the GTase activity of class A PBPs10. If rodA encoded the sigM 136 
dependent GTase responsible for growth in the presence of MOE, artificial upregulation of rodA 137 
should restore MOE resistance in a sigM mutant. Figure 2f shows that a sigM mutant was at least 10-138 
fold more sensitive to MOE than the isogenic wild type strain. Introduction of a xylose-inducible copy 139 
of rodA into the sigM mutant made no difference in the uninduced state but in the presence of 140 
xylose, resistance to MOE was boosted almost to the wild type level. In a control experiment, a 141 
xylose-inducible copy of the related ftsW gene was induced in the sigM mutant but no such rescue 142 
was detected (not shown). Thus, induction of rodA is sufficient to restore growth to a sigM mutant 143 
when the GTase activity of class A PBPs is inhibited, highlighting this gene as a strong contender for 144 
the missing GTase.  145 
To rule out MreC and/or MreD as the missing GTase, we carried out a series of similar experiments 146 
in which we depleted or overproduced the proteins. Neither mreC nor mreD generated a synthetic 147 
lethal phenotype when combined with a ponA mutation (Supplementary Fig. 2). Furthermore, 148 
overexpression of mreBCD does not rescue ponA lethality on PAB medium, nor provide resistance to 149 
MOE in a sigM mutant. Since MreC and MreD are probably members of a large protein complex 150 
required for elongation, including not just RodA but also RodZ, class B PBPs and the MreB proteins21, 151 
it seems possible that the MOE sensitivity of mreC and mreD mutants is due to indirect effects on 152 
function of the elongation complex. 153 
A potential antibiotic inhibitor of the missing GTase 154 
In parallel with the above experiments, we carried out a chemical genetic screen for inhibitors of the 155 
missing GTase. Culture extracts from 2,387 different actinomycete strains were screened at Demuris 156 
Ltd for differential antibiotic activity against wild type B. subtilis (168CA) and the Δ4 strain. An 157 
example of a pair of plates challenged with discs containing extracts from 8 different candidates is 158 
shown in Figure 3a. Discs 3 and 6 showed reproducible differential activity (larger zones of 159 
inhibition) on the Δ4 vs the Wt. Other extracts showed either no significant activity or large zones on 160 
both strains (disc 8). Strain DEM20654 (disc 3) was chosen for further study, based on its robust 161 
production of soluble inhibitory activity in liquid medium and reasonably rapid growth properties.  162 
In preliminary experiments strain DEM20654 appeared to make at least three different bioactive 163 
molecules. One was a polyene compound, with strong antifungal properties. A second was 164 
antibacterial but triggered the DNA damage response on a B. subtilis reporter strain and so was 165 
thought not likely to be the compound of interest. The third activity, designated 654/A, showed a 166 
substantially larger zone of inhibition on the Δ4 strain than on the wild type (Fig. 3b). A control 167 
antibiotic (citrox) produced equal zones of inhibition on both strains, as did various other antibiotics 168 
tested (Supplementary Fig. 3). The activity of interest also inhibited the growth of Staphylococcus 169 
aureus but not the eukaryotic fission yeast, Schizosaccharomyces pombe.  170 
Purified 654/A causes cell lysis and has enhanced activity on the Δ4 mutant 171 
The HPLC purified active material contains three UV peaks that run very close to each other 172 
(Supplementary Fig. 4). Peak 1 and the minor peak 3 are probably closely related as they have similar 173 
UV absorbance profiles. We do not yet know whether any single peak corresponds to the active 174 
molecule, or whether a combination is needed for the activity. Nevertheless, availability of this bulk 175 
material enabled more extensive analysis of effects of the putative novel antibiotic on cells. Cultures 176 
of the wild type and Δ4 mutants were examined by time lapse microscopy in a microfluidic device 177 
before and after exposure to a growth inhibitory concentration of 654/A. Representative videos are 178 
shown in Supplementary Videos 1-3, and individual frames from the Δ4 strain are shown in Figure 179 
3c. Compound treatment caused an arrest in growth of the Δ4 mutant followed by various lytic 180 
events culminating in: complete cell destruction, formation of phase pale bulbous cells, or formation 181 
of chains of small phase dark “minicells”. In general, lysis tended to occur at cell poles or mid cell 182 
potential division sites. As expected, at this concentration, wild type cells showed only mild 183 
morphological defects but at a higher concentration of 654/A, the effects were similar to those 184 
shown for the mutant in Figure 3c (Supplementary Video 4). The phenotypic events documented are 185 
typical of mutants affected in cell wall synthesis, consistent with the notion that 654/A might work 186 
on the missing GTase.  187 
Effects of 654/A activity on the Δ4 mutant are dependent on rodA expression levels 188 
If the 654/A compound acted on the SEDS proteins, overexpression of the rodA and/or ftsW genes 189 
should ameliorate the effects of the compound. It emerged that overexpression of rodA did indeed 190 
increase resistance of the ponA mutant to 654/A. Figure 3d shows a typical experiment in which a 191 
ponA strain carrying an extra copy of rodA under control of Pxyl was exposed to 654/A. As expected, 192 
increasing concentrations of 654/A resulted in progressively larger zones of inhibition. However, 193 
addition of xylose to induce overproduction of RodA resulted in greatly reduced zones of inhibition 194 
at all three concentrations of 654/A. Quantitation of the effects of different levels of RodA 195 
overproduction (Fig. 3e) revealed a gradual amelioration of inhibition with increasing xylose 196 
concentration. Similar results were obtained in liquid growth experiments (Supplementary Fig. 5), 197 
which also showed that the rescue was not due to xylose addition. These results demonstrated that 198 
overproduction of RodA counteracts the inhibitory effects of 654/A on B. subtilis.  199 
Moenomycin and 654/A act synergistically 200 
If MOE and 654/A acted on different forms of GTases with overlapping functionality the two 201 
antibiotics should behave synergistically. Indeed, in disc diffusion assays, cells exposed to sub-lethal 202 
concentrations of the combination of 654/A and MOE were killed in the zone between the two 203 
antibiotic discs (arrowed; Fig. 3f). No such synergistic killing effect was evident in the zone between 204 
654/A and the citrox control. We extended this analysis to a checkerboard experiment (Fig. 3g) in 205 
which cultures in microwell plates were exposed to the two antibiotics across a range of 206 
combinatorial concentrations. Severe inhibition of growth occurred in many of the wells containing 207 
sub-MIC concentrations of both antibiotics (Fig. 3g, below and to the left of the MIC lines), indicating 208 
a strong synergistic effect. 209 
 210 
Discussion 211 
The genes encoding SEDS proteins were identified decades ago through mutations generating a 212 
round cell, division or sporulation defective phenotype8,22. The mutant phenotypes are thus very 213 
similar to those generated by mutations in genes encoding the class B PBPs. Indeed, in endospore 214 
forming bacteria, there is also a sporulation specific class B PBP called SpoVD, and a SEDS protein 215 
with indistinguishable mutant phenotype called SpoVE23. In many cases the SEDS gene lies 216 
immediately adjacent to a class B PBP gene, for example the mrdA and mrdB genes of E. coli24, 217 
suggesting that their functions might be connected. There are even examples of organisms in which 218 
the two moieties are naturally fused. We obtained DNA from one such organism, Lachnoclostridium 219 
phytofermentans ISDg (accession WP_012199367.1) and confirmed by direct sequencing that the 220 
two genes are indeed fused in a single open reading frame (not shown).  221 
The primary sequences of the various classes of SEDS proteins (RodA, FtsW, SpoVE), as well as 222 
patterns of transmembrane predictions and conserved residues, are very similar, suggesting that 223 
they are functionally equivalent. It has been suggested, based on the extremely hydrophobic nature 224 
and the multi-transmembrane character, that SEDS proteins might act as flippases, responsible for 225 
delivering the membrane associated PG precursor molecule, lipid II to the class B PBP, ready for 226 
transpeptidation25. However, recently, alternative candidates for the lipid II flippases have been 227 
identified in the MurJ and Amj proteins, in E. coli and B. subtilis15,26. Our results suggest, instead, that 228 
RodA, and possibly the other SEDS proteins8, are GTases that work together with their cognate class 229 
B PBP transpeptidases to catalyse key steps in bacterial cell wall morphogenesis. In support of this 230 
idea, Ovchinnikov et al.27 reported that the predicted transmembrane structure of FtsW shares 231 
similarity with dolichyl-diphosphooligosaccharide-protein glycosyltransferase, which is a GTase that 232 
transfers an oligosaccharide from a lipid-linked precursor to nascent glycoproteins. Recently 233 
published papers have provided direct biochemical evidence9,28 for GTase activity. It remains 234 
possible that the SEDS proteins have both flippase and GTase activities. If so, this would mean that, 235 
in principle, the SEDS proteins could take a lipid II molecule from inside the cytoplasmic membrane, 236 
flip it and then directly transfer the substrate onto a glycan strand in the wall. This would contrast 237 
with the class A PBPs, which, due to their GTase domain lying outside the membrane, presumably 238 
rely on a flippase to provide the substrate. 239 
Consistent with the notion of a direct role for the RodA protein in cell wall elongation, depletion of 240 
rodA in a mutant lacking class A PBPs results in growth arrest. However, the rounded phenotype 241 
characteristic of rodA mutants of both B. subtilis and E. coli, did not emerge. We interpret this to 242 
support the idea that RodA is essential for the cell elongation process and that in its absence the 243 
class A PBPs manufacture PG in an uncontrolled manner, leading to the rounded phenotype. This is 244 
reminiscent of our previous finding that in mreB mutants of B. subtilis delocalization of PBP1A is 245 
responsible for the cell wall bulging that leads to lysis20. It seems unlikely that this loss of growth 246 
could be attributed to loss of flippase activity, given that B. subtilis has multiple flippases of the MurJ 247 
family and an alternative flippase in Amj15. It thus appears that RodA (and possibly FtsW during cell 248 
division) are the key GTases responsible for controlled (morphogenic) wall synthesis. The role of the 249 
class A PBPs may be to provide bulk PG synthesis when wall synthesis is damaged or perturbed, or to 250 
increase the overall growth rate of cells. Altogether, this would be a paradigm shifting change in our 251 
thinking about the roles of PBPs in cell wall synthesis. 252 
If RodA and the other SEDS proteins do indeed turn out to be GTases, they may represent one of the 253 
most important new antibiotic targets discovered in several decades. The genes are very widely 254 
conserved and essential for growth and viability under normal conditions. The crucial advantages of 255 
these kinds of proteins as targets for antibiotics lies in their availability on the outer surface of the 256 
permeability barrier imposed by the cytoplasmic membrane, and on the absence of equivalent 257 
functions in humans. Furthermore, inhibitors with only a single lethal protein target tend to suffer 258 
from problems of resistance, which is another reason why dual targeting fluoroquinolones and muti-259 
targeting β-lactams have been so successful. Assuming that RodA and FtsW are both GTases, it may 260 
be possible to obtain inhibitors of both, and thus achieve dual lethal targeting. Indeed, we have not 261 
excluded the possibility that 654/A has some activity on FtsW. Finally, the existence of a naturally 262 
occurring bioactive compound that targets RodA reinforces the notion that these proteins are crucial 263 
for cell viability and fitness, and the compound may provide a rich new source of starting points for 264 
future antibiotics.  265 
 266 
Methods 267 
Bacterial strains, plasmids, primers and growth conditions 268 
The bacterial strains, plasmid constructs and primers for PCR analysis in this study are shown in 269 
Supplementary Table 2. DNA manipulations were carried out using standard methods. Nutrient agar 270 
(Oxoid), LB or Difco antibiotic medium 3 (PAB) plates were used for growth on solid medium 271 
supplemented, as required, with MSM (0.5 M sucrose, 20 mM maleic acid and 20 mM MgCl2), IPTG 272 
or xylose at 30 or 37°C. Liquid cultures of Bacillus strains were grown at 30 or 37° C in LB medium or 273 
nutrient broth (NB, Oxoid) with MSM at 37° C. For genetic selections, antibiotics were added to 274 
media at the following concentrations: 100 μg/ml ampicillin, 1 μg/ml erythromycin, 2 or 5 μg/ml 275 
kanamycin (or 15 μg/ml with 20 mM Mg++), 50 μg/ml spectinomycin and 5 μg/ml chloramphenicol. 276 
Citrox was obtained from Citrox Ltd, Middlesbrough, UK. 277 
 278 
pG+host10 and the derivatives used for marker free mutants of Class A PBPs 279 
pG+host10 plasmid was constructed as a derivative of pG+host9 carrying an ampicillin resistance 280 
cassette and thermosensitive replication29. The bla gene was amplified by PCR using RE05 / 06 281 
primers and plasmid pLOSS* as substrate. The PCR product and pG+host9 were digested by ClaI and 282 
XhoI and cloned into E. coli TG1 to generate plasmid pG+host10. Upstream and downstream DNA 283 
regions (500-600 bp) of ponA coding sequence were amplified by PCR using primers RE01 / 02 and 284 
RE03 / 04, respectively and double digested by NotI/EcoRI and EcoRI/KpnI, respectively. Digested 285 
PCR products were ligated to digested plasmid pG+host9 (NotI/KpnI), cloned into E. coli TG1 to 286 
obtain plasmid pG+host9::ΔponA. Similarly, upstream DNA regions of pbpD and pbpF coding 287 
sequences were amplified by PCR with primers RE07-08 and RE11 / 12 whereas downstream region 288 
of pbpD and pbpF were amplified using primers RE09-10 and RE13 / 14, respectively. Upstream and 289 
downstream PCR products were double digested by NotI/EcoRI and EcoRI/HindIII respectively. Each 290 
of the pbpD or pbpF flanking DNA-fragments were ligated to double digested NotI/HindIII pG+host10 291 
plasmid, then cloned into E. coli TG1 to generate plasmids pG+host10::ΔpbpD and pG+host10::ΔpbpF. 292 
Plasmids obtained were checked by digestion and PCR sequencing with primers AG21 to 23.  293 
The marker-free deletion mutants of the B. subtilis vegetative class A PBPs were obtained by 294 
consecutive multi-step reactions using pG+host9 derivatives as described previously (see also above 295 
and Supplementary Table 2). All class A PBP mutants were selected on NA plates with 10 mM or 20 296 
mM MgSO4. Marker-free deletions were confirmed by PCR using primers listed in Supplementary 297 
Table 2.  298 
 299 
pLOSS-Pspac-ponA 300 
To construct pLOSS-Pspac-ponA plasmid, a 2846 bp fragment of ponA coding sequence and its 301 
putative terminator was amplified by PCR using primers AG11 / 12. PCR product and pLOSS* 302 
plasmid30 were digested by NotI and SpeI, then ligated and cloned in E. coli DH5α to generate 303 
plasmid pLOSS-Pspac-ponA. The presence of the insert was verified by plasmid digestion and plasmid 304 
sequencing using primers AG18 / 19. 305 
Pspac-rodA 306 
To generate a strain with conditional expression of rodA the 5’ end of the coding sequence was 307 
cloned as an XbaI-EcoRV fragment from pRD163, ligated into pSG441 digested with XbaI and blunted 308 
ClaI. The resulting plasmids, pRD159, once integrated into genome of B. subtilis 168CA, gave 309 
kanamycin resistant strains that are dependent on IPTG (including strain YK2245).  310 
amyE::Pxyl-rodA and -ftsW  311 
For overexpression of the ftsW and rodA genes each gene was cloned into an amyE integrating 312 
construct under the control of the Pxyl promoter. PCR generated DNA fragments (using oligo pairs 313 
A328 / A329 for ftsW and A330 / A331 for rodA) containing the entire coding sequences of FtsW and 314 
RodA together with their native ribosome binding sites, were cloned into plasmid pJPR1 to link them 315 
to the Pxyl promoter, using the restriction sites XbaI and NotI. The resulting derivatives of pJPR1 316 
(pRD164 encoding ftsW and pRD163, for Pxyl-rodA) were then transformed into 168CA selecting for 317 
double crossover insertions on the basis of chloramphenicol resistance and loss of amylase activity, 318 
to generate strains YK2250 (ftsW) and YK2249 (rodA). 319 
RNA isolation and RNA-seq 320 
Wild-type (168CA) and Δ4 (AG157) strains were cultured in NB at 37°C until mid-exponential phase. 321 
Total RNA was isolated using a Total RNA purification Plus Kit (Norgen Bioteck). RNA quality was 322 
assessed by Agilent RNA 6000 Nano Kit. The RNA sequencing was performed at PrimBio Research 323 
Institute (USA). 324 
 325 
Microscopic imaging  326 
For snapshot live cell imaging, cells were mounted on microscope slides covered with a thin film of 327 
1.2% agarose in water, essentially as described previously31. Images were acquired with a Rolera EM-328 
C2 (Q-imaging) camera attached to a Nikon TiE microscope. The images were acquired and analysed 329 
with METAMORPH version 6 (Molecular Devices). 330 
For the time lapse images (Fig. 3c) the strains were cultured overnight on LB medium supplemented 331 
with MgSO4 to a final concentration of 20 mM, then diluted to an OD600nm of 0.05. Samples of cells 332 
were loaded into B04A microfluidic plates (ONIX, CellASIC) at 4 psi for 15 sec and the loading channel 333 
was subsequently washed for 30 sec at 3 psi. Throughout imaging, the media flow rate and 334 
temperature were maintained at 2 psi and 37oC, respectively. Compound was added to the cells by 335 
switching the media flow channel using the CellASIC ONIX FG software (v. 5.0.1.0). Cells were 336 
visualised using a Nikon Ti microscope equipped with a Nikon Plan Apo 100x/1.40 oil objective. 337 
Images were captured every 5 mins using FRAP-AI v. 7.7.5.0 software (MAG Biosystems, Molecular 338 
Devices). Images and videos were processed using ImageJ (NIH). 339 
 340 
Moenomycin (MOE) growth assays 341 
Strains were grown in a suitable culture medium overnight at 30°C, then diluted ~1:200 into fresh 342 
medium, grown until mid-exponential at 37°C and then diluted again in fresh medium to a suitable 343 
OD600nm (usually between 0.03 and 0.1). Using a multichannel pipette, 100 μl of diluted-cells were 344 
dispensed into each well of a 96-well plate containing 100 μl volumes of the antibiotic to be tested 345 
pre-diluted in the culture medium. The microtiter plate was then incubated with shaking for up to 16 346 
h at 37°C in a microtiter plate reader (FluoStar Galaxy, BMG Lab Technologies). Readings of the 347 
OD600nm was taken every 5 to 6 min. For the determination of MOE sensitivity a wide range of MOE 348 
concentrations were employed ranging from 4 ng/ml to 20 μg/ml. For moenomycin and 654/A 349 
synergy test, MOE was diluted in a 2-fold series along the horizontal axis and 654/A in the vertical. 350 
 351 
Inhibitor screening methods 352 
Establishment of optimal growth conditions for screening 353 
Screening was carried out by comparing the effects of actinomycete natural products on growth of 354 
wild type (168CA) and Δ4 (AG157) strains. A range of pilot experiments were used to define the 355 
optimal conditions for culture growth and extract testing (using a randomly selected 96 well plate 356 
containing actinomycete extracts). From these experiments a protocol suitable for high throughput 357 
screening was established, as follows.  358 
Actinomycete samples 359 
Actinomycetes were cultured on suitable agar plates, typically GYM medium (glucose 4 gl-1, yeast 360 
extract 4 gl-1, malt extract 10 gl-1, pH 7.0) at 30°C for several days until stationary phase was reached. 361 
The total agar plus biomass was harvested and crushed by passage through a syringe then frozen at -362 
80°C and thawed. The material was centrifuged at 5000 x g for 10 min. The supernatant was 363 
collected and stored at -80°C until use. 364 
Indicator cell preparation 365 
Wild type and Δ4 strains were cultured overnight in LB + 20 mM MgSO4 (LB/Mg) with shaking at 366 
30°C. On the day of screening the overnight culture was diluted to an OD600nm of 0.05 in 10 ml fresh 367 
LB/Mg and incubated (160 rpm) at 30°C. When the culture reached an OD600nm of 0.1 ± 0.02, the cells 368 
were serially diluted to the required density.  369 
Agar plate screening 370 
For agar plate screening, 50 ml of NA + 20 mM MgSO4 (NA/Mg) was poured into square 100 mm x 371 
100 mm petri dishes. After drying, 3 ml of a 10-3 dilution of test culture was poured onto the plate 372 
and swirled to cover the plate. Excess liquid was poured off and the plates were allowed to dry. 373 
Extracts from actinomycete plate or liquid cultures (approx. 2 μl) were spotted onto the plates using 374 
a pinning device, allowed to dry and then the plates were incubated overnight at 30°C. Zones of 375 
inhibition were recorded after 15 h. 376 
Microplate (liquid culture) screening 377 
Thawed Actinomycete extract samples (10 µl) were dispensed into 96-well plates in duplicate and to 378 
each well was added 100 µl of the wild type or Δ4 strain (OD600nm of 0.05). Plates were incubated in 379 
orbital shakers overnight (18 h). The final OD600nm was measured using a plate reader and wells with 380 
significantly reduced density were identified.  381 
Disc diffusion assay 382 
These were carried out as described under agar plate screening except that 10 µl of crude or 383 
fractionated extract was spotted onto 5 mm discs cut from Fisher chromatography paper (CHR200), 384 
which were then placed on dried, seeded NA plates. Plates were incubated at 30°C for 18 h and the 385 
diameter of any zone of inhibition measured. Citrox was used as a control antibiotic for convenience 386 
and because it gave very reproducible inhibition under a wide range of conditions and for many 387 
different organisms. 388 
The high throughput screen 389 
Based on preliminary results, the microplate (liquid culture) screening method was chosen for the 390 
full screen. Extracts from a total of 2387 Actinomycete strains from the Demuris Ltd. collection were 391 
screened for activity against the wild type and Δ4 strains. Out of 2387 extracts, 679 showed some B. 392 
subtilis killing: a typical hit rate for actinomycete extracts on Firmicutes. A total of 102 candidate hits 393 
(reducing OD600nm in the Δ4 strain compared with the wild type) were regrown and crude culture 394 
supernatants were screened again for differential activity on the two strains using a disc diffusion 395 
assay.  396 
Hit prioritization 397 
Based on comparison of the liquid culture and disc diffusion results three strains, DEM20654, 398 
DEM21374 and DEM31701 were prioritised as making compounds with substantially higher activity 399 
on the Δ4 strain compared to the wild type. Each of the three strains were cultured in a range of 400 
different growth media and retested. DEM20654 was chosen for further work based on its robust 401 
production of a specific inhibitor in a range of different liquid media.  402 
Bulk purification of 654/A 403 
DEM20654 was grown in 16 l of GMY medium (glucose, malt & yeast extract), supplemented with 404 
0.5 g l-1 oat flour, and a series of chemical fractionation procedures were used to isolate nearly pure 405 
material for further study. After growth to stationary phase, the mycelia were separated from the 406 
culture supernatant by filtration. Amberlite XAD-16 resin (20 g l-1) was applied to the supernatant. 407 
After overnight incubation under agitation, the beads were filtered off and washed with deionised 408 
water. Elution was carried out using methanol (4 l). The solvent was evaporated to an aqueous 409 
extract. The pH of the aqueous extract was adjusted to 10 using sodium hydroxide followed by twice 410 
extracting with 2 vols of ethyl acetate. The organic layer was then dried under vacuum in 10 g of 411 
silica gel. The dried material was subjected to: silica flash chromatography (Biotage® 100 g SNAP 412 
Ultra cartridge), using an ethyl acetate / methanol (0-100%) gradient; size exclusion chromatography 413 
using methanol and LH20 resin as stationary phase; and high performance liquid column 414 
chromatography (HPLC) on an Agilent 1260 Infinity II LC system (Agilent Technologies INC, Santa 415 
Clara, CA, USA) equipped with a reverse-phase C18 column (Phenomenex, CA, USA). The HPLC 416 
separated fractions were eluted with a gradient of acetonitrile in water from 0 to 100% in 45 min at 417 
1 ml min-1 flow rate. Individual fractions were subjected to activity tests against B. subtilis strains by 418 
disc diffusion assays. 419 
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Table 1. Candidate genes for the missing GTase and test results for sensitivity of the mutants to 440 
MOE. 441 
 442 
Figure 1. Use of MOE sensitivity to screen for missing GTase candidate genes. 443 
a, Relative MOE sensitivity of the sigM mutant and resistance of the ponA and Δ4 mutant compared 444 
to the wild type. Overnight cultures of each strain were diluted (10-fold series; left to right) and 10 µl 445 
spots were placed on NA containing MOE at 10 µg/ml. Right hand spots show the last three dilutions 446 
plated on NA with no MOE. sigM spottings were done in duplicate. 447 
b, Synthetic lethality of a Δ4 mutant in a ΔsigM background. Growth on NA plates with or without 1 448 
mM IPTG of strains AG221 (Δ4 pLOSS-Pspac-ponA) and AG831 (Δ4 pLOSS-Pspac-ponA ΔsigM::kan) at 449 
30°C. 450 
c, Hypersensistivity of rodA, mreC and mreD mutants compared to wild type, ponA and Δ4 strains. 451 
Disc diffusion assays on MSM plates using 10 µg MOE per disc.  452 
The experiments have been repeated several times during the course of the project, producing 453 
consistent results. The figures are representative of at least two independent experiments. 454 
 455 
Figure 2. Evidence for RodA as a candidate for the missing GTase. 456 
a, Synthetic lethality of a rodA mutation in a ΔponA and Δ4 mutants. Growth on NA/MSM plates 457 
with or without 1 mM IPTG of strains YK2245 (Pspac-rodA), YK2246 (ΔponA::spc Pspac-rodA) and 458 
YK2242 (Δ4 Pspac-rodA) at 30°C. 459 
b, Growth profiles of YK2245 (Pspac-rodA), YK2246 (ΔponA::spc Pspac-rodA) and YK2242 (Δ4 Pspac-rodA) 460 
strains in NB/MSM with or without 1 mM IPTG at 37°C. 461 
c, Morphological effects of RodA depletion in ΔponA and Δ4 mutants. Phase-contrast and the 462 
corresponding cell membrane-stained images of typical fields of cells of YK2245 (Pspac-rodA), YK2246 463 
(ΔponA::spc Pspac-rodA) and YK2242 (Δ4 Pspac-rodA) cultured in NB/MSM medium with or without 1 464 
mM IPTG at 37°C. Time (h) of cultivation of cells after removal of IPTG is indicated. Scale bar 465 
represents 3 μm. 466 
d, Rescue of the growth defect of a Δ4 mutant by overexpression of rodA, but not ftsW. Growth on 467 
PAB plates with or without 1 mM IPTG, or 1% xylose, of strains YK2256 (Δ4 pLOSS-Pspac-ponA 468 
amyE::Pxyl-rodA) and YK2257 (Δ4 pLOSS-Pspac-ponA amyE::Pxyl-ftsW) at 30°C. 469 
e, Rescue of the synthetic lethality of Δ4 and ΔsigM strains by the overexpression of rodA. Growth 470 
on NA plates with or without 1 mM IPTG, or 1% xylose of strain YK2259 (Δ4 pLOSS-Pspac-ponA 471 
amyE::Pxyl-rodA ΔsigM::kan) at 30°C. 472 
f, Restoration of resistance to MOE in a sigM mutant overproducing RodA. Wild type (168CA), AG494 473 
(ΔsigM) or YK2268 (ΔsigM amyE::Pxyl-rodA) were grown in the presence (bottom) or absence (top) of 474 
xylose, and treated with MOE as indicated.  475 
All the results in the figure are representative of at least two independent experiments. 476 
 477 
Figure 3. Isolation and characterization of a putative inhibitor of the missing GTase. 478 
a, Validation of a selection of hits from rescreening for antimicrobial activity using disc diffusion test. 479 
Fresh culture media extracts of different Actinomycete strains were prepared and tested against B. 480 
subtilis Wt and the Δ4 mutant. Discs 3 (Strain DEM20654) and 6 showed reproducible differential 481 
activity (larger zones of inhibition) on the Δ4 vs the Wt strain. Other extracts showed either no 482 
significant activity or large zones on both strains (disc 8). 483 
b, Confirmation of the differential activity of purified 654/A on Δ4 relative to a control by disc 484 
diffusion assay. 485 
c, Effects of purified 654/A on the Δ4 mutant. Individual frames are extracted from the video in 486 
Supplementary Video 1. Numbers in the bottom left corner of each frame represent time elapsed in 487 
the video. Examples of different lytic events are shown by asterisks (complete cell destruction), 488 
arrows (formation of phase pale bulbous cells), and arrowheads (formation of chains of small phase 489 
dark “minicells”).. Scale bar represents 10 µm. 490 
d,e, Increased 654/A resistance in ponA mutant cells containing an extra xylose-inducible copy of 491 
rodA (Pxyl-rodA). d, Disk diffusion tests were done with three different concentrations of 654/A 492 
(corresponding to 2, 5 or 10 µl amounts of purified material, left to right). Citrox was used as a 493 
control. Duplicate plates without or with 4% xylose (to induce overexpression of rodA), as indicated, 494 
were inoculated with strain YK2251 and incubated overnight. e, Dose response results for three 495 
different concentrations of 654/A, and at a range of concentrations of xylose. Average zones of 496 
inhibition were measured for duplicate disc diffusion tests and expressed as a percentage of the 497 
inhibition zone for the control antibiotic (citrox) measured on the same plate.  498 
f,g, Synergy between 654/A and MOE as demonstrated by disc diffusion (f) or checkerboard analysis 499 
(g) with the wild type strain (168CA). f, MOE, 654/A and a control antibiotic (citrox) were placed on a 500 
lawn of bacteria on an NA plate. The arrow points to an enhanced zone of clearing at the interface of 501 
the MOE and 654/A sub-inhibitory regions. g, Serial dilutions (2-fold) of MOE and 654/A were 502 
transferred to a 96 well plate, with MOE along the horizontal axis and 654/A in the vertical as 503 
indicated below and to the left. A dilute culture of wild type bacteria was used to inoculate each well 504 
and the plate was incubated for 24 h with continuous optical density monitoring. Dotted lines 505 
identify the minimum inhibitory concentrations derived by reference to the wells containing only 506 
one antibiotic (top row for MOE and far right column for 654/A). OD600 readings at the 18 h time 507 
point were used to calculate percentage inhibition values (shown in each rectangular segment) 508 
relative to the no antibiotic control.  509 
All the results in the figure are representative of at least two independent experiments. 510 
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